Zorkina, Y.; Abramova, O.; Ushakova, V.; Morozova, A.; Zubkov, E.; Valikhov, M.; Melnikov, P.; Majouga, A.; Chekhonin, V.
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 2020, 25, 5294.
https://doi.org/10.3390/molecules25225294
AMA Style
Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V.
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules. 2020; 25(22):5294.
https://doi.org/10.3390/molecules25225294
Chicago/Turabian Style
Zorkina, Yana, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga, and Vladimir Chekhonin.
2020. "Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations" Molecules 25, no. 22: 5294.
https://doi.org/10.3390/molecules25225294
APA Style
Zorkina, Y., Abramova, O., Ushakova, V., Morozova, A., Zubkov, E., Valikhov, M., Melnikov, P., Majouga, A., & Chekhonin, V.
(2020). Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules, 25(22), 5294.
https://doi.org/10.3390/molecules25225294